Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1995-2-24
pubmed:abstractText
During human immunodeficiency virus infection and allergic diseases, characterized by a dominant T helper (Th) 2 response, overproduction of prostaglandin E2 (PGE2) is observed. In this paper we studied the effect of PGE2 on interleukin (IL)-12 synthesis, because this cytokine has been described to be essential in induction of Th1 responses. IL-12 synthesis was induced in monocytes that were stimulated with Neisseria meningitidis-derived lipopolysaccharide in whole blood cultures. PGE2 almost completely inhibited lipopolysaccharide induced IL-12 production, whereas IL-6 production was only partially inhibited by PGE2. In contrast, the production of IL-10 was approximately twofold enhanced at these conditions. The effects of PGE2 were due to its cAMP-inducing capacity, since they could be mimicked by other cAMP inducers. Recombinant human IL-10 also inhibited IL-12 and IL-6 production. However, the inhibitory effect of PGE2 on IL-12 production was independent of IL-10 since neutralizing anti-IL-10 antibodies were unable to reverse this inhibition. These results suggest that the capacity of an antigen to induce PGE2 synthesis may play a crucial role in the development of either a Th1 or Th2 response.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-1349533, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-1357073, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-1572689, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-1673147, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-1680337, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-1713608, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-1845802, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-1958288, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-2140386, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-2162906, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-2174560, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-2317944, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-2523712, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-2642948, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-2855581, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-3422080, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-3500054, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-7901851, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-7907633, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-7908324, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-8096238, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-8097338, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-8097524, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-8098733, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-8098942, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-8100999, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-8102388, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-8103338, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-8242755, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-8390534, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-8391271, http://linkedlifedata.com/resource/pubmed/commentcorrection/7836930-8450057
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0022-1007
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
181
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
775-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.
pubmed:affiliation
Department of Autoimmune Diseases, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't